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Abstract 
Introduction: Insulin resistance (IR) is a key and early pathogenetic mechanism of cardiometabolic diseases with huge potential if de-
tected early and mitigated, for lowering the burden of the disease. Available data are conflicting to what extent adult thyroid dysfunction 
is associated with IR. Therefore, we aimed to investigate the association and to identify which thyroid parameters are predictors of IR. 
Material and methods: After undergoing basic anthropometric and biochemical studies including thyroid hormones, oral glucose tol-
erance test (OGTT), and insulin, 1425 middle-aged individuals were divided into three groups according to thyroid parameters: overt 
hypothyroidism (OH), subclinical hypothyroidism (SH), and euthyroidism (EU). 
Results: The homeostasis model assessment of IR (HOMA-IR), fasting insulin, and two-hour glucose levels of OGTT showed a steady, yet 
insignificant, increase from EU through SH to OH. The strongest noted correlations were those of insulin levels with free triiodothyronine/ 
/free thyroxine (FT3/FT4) ratio (r = 0.206, p < 0.001) and FT3 (r = 0.205, p < 0.001). Also in the case of HOMA-IR, the only statistically 
significant correlations were observed for FT3 (r = 0.181, p < 0.001) and the FT3/FT4 ratio (r = 0.165, p < 0.001). Among other thyroid 
hormones, linear logistic regression proved the FT3/FT4 ratio as the only significant predictor of HOMA-IR (linear coefficient = 5.26, 
p = 0.027) and insulin levels (linear coefficient = 18.01, p = 0.023), respectively. Thyroid-stimulating hormone was not associated with IR 
in either correlation or regression analysis. 
Conclusions: The FT3/FT4 ratio should be more emphasised in the diagnosis and treatment of thyroid disorders. Patients could benefit 
from a pharmacological reduction of the FT3/FT4 ratio, potentially leading to a decrease in insulin resistance, and thus a corresponding 
decrease in the risk of the cardiometabolic diseases. (Endokrynol Pol 2021; 72 (1): 8–13)
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Introduction
Thyroid disorders (TDs) are common conditions with 
potentially devastating health consequences that affect 
all populations worldwide. Both hypothyroidism and 
hyperthyroidism have their overt, clinically manifested 
forms caused by serum abnormities of the thyroid gland 
hormones (free thyroxine [FT4] and free triiodothyro-
nine [FT3]). Whereas subclinical forms of TDs show 
normal serum levels of free thyroid hormones, there 
are inverse feedback changes in thyroid-stimulating 
hormone (TSH) levels [1–3].
The prevalence of overt hypothyroidism (OH) in 
the general adult population varies between 0–2% 
and 5–3% in Europe and between 0–3% and 3–7% in 
the USA, depending on the definition used [1]. The 
diagnosis of subclinical hypothyroidism (SH) is bio-
chemical, solely based on thyroid function testing. In 
iodine-sufficient populations, SH affects up to 10% of 
the population [2]. The prevalence of hyperthyroidism 
is 0.8% in Europe and 1.3% in the USA [3].
Proper thyroid function is important for the pre-
vention of cardiometabolic diseases. The importance 
of thyroid hormones in maintaining cardiovascular 
homeostasis can be deduced from clinical and ex-
perimental data showing that even subtle changes in 
thyroid hormone concentrations adversely influence 
the cardiovascular system. Some potential mechanisms 
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insulin. None of them had a history of thyroid disorders, and they 
were not treated with any drugs known to affect thyroid function.
The study was conducted according to the principles stated in the 
Declaration of Helsinki. The study was approved by the Ethics Com-
mittee of University Hospital Olomouc and Faculty of Medicine and 
Dentistry, Palacký University Olomouc (Approval No. 20/11). To be 
included in the study, all subjects signed informed consent forms.
Laboratory analysis
Venous blood samples were drawn in the morning after a 12-hour 
fast. After centrifugation, the serum was used for analyses on the 
day of blood collection. Glucose was analysed on a Cobas 8000 
(Roche Diagnostics GmbH, Manheim, Germany) using the hexo-
kinase method. Also on the Cobas 8000, TSH, FT4, and FT3 were 
measured by electrochemiluminescence immunoassay. Insulin 
was determined by chemiluminescent microparticle immunoassay 
on Architect i1000SR (Abbott Laboratories, Chicago, IL, USA). All 
analyses were performed according to the manufacturer’s instruc-
tions and after verification of methods.
Statistical analysis
Statistical analysis was performed using the computing environ-
ment R (R Foundation for Statistical Computing, Vienna, Austria; 
http://www.r-project.org/). All numerical variables were charac-
terised with descriptive statistics. The Wilcoxon signed-rank test 
(p-value) was used to compare numerical characteristics between 
the given subgroups. Extreme values of variables were found and 
excluded using the inner and outer fences method. All variables fol-
lowed normal or near-normal distribution. Correlations of selected 
variables were quantified with Pearson’s correlation coefficient (r), 
and the level of significance (p) was determined. Multivariate linear 
regression was performed to examine the relationships between 
thyroid hormones, age, and sex, as regressors of the dependent 
variables insulin and HOMA-IR. Due to a hyperbolic dependence 
of IR through the whole spectrum of TDs, evidenced by studies [5], 
the correlation and linear regression analyses were performed only 
in hypothyroid (both overt and subclinical) and euthyroid subjects. 
In other words, IR grows in both hypo- and hyper-thyroidism (in 
comparison with normal IR state in euthyroidism), whereas thyroid 
parameters change linearly through the whole spectrum. Hyper-
thyroidism was chosen for exclusion because of the expected lower 
prevalence in the study population. P-value of less than 0.05 indicates 
statistical significance. The following formula was used to calculates 
HOMA-IR (glucose levels in mmol/L, insulin levels in mIU/L) [10]:
HOMA-IR = (glucose × insulin)/22.5
Results
Characteristics of the study population
The basic characteristics of all subjects with respect 
to a particular TD are shown in Table 2. Only 23 in-
dividuals from the whole group met the criteria for 
hyperthyroidism; therefore, due to the disproportion 
to the size of the other subgroups, we did not include 
them into the table. As expected, most individuals had 
normal thyroid parameters, followed by the OH and 
SH subgroups, respectively. Between the subgroups, 
differences of the tested parameters, apart from the 
thyroid parameters, did not reach statistical signifi-
cance. There were no apparent trends of the parameters 
between subgroups except for insulin, HOMA-IR, and 
linking the two conditions are dyslipidaemia, endo-
thelial dysfunction, blood pressure or body weight 
changes, and direct effects of thyroid hormones on the 
myocardium [4]. Moreover, thyroid hormones have 
an effect on glucose metabolism and probably on the 
development of insulin resistance (IR). In hyperthy-
roidism, impaired glucose tolerance may be the result 
of mainly hepatic IR, whereas in hypothyroidism the 
available data suggest that IR of peripheral tissues 
prevails [5]. However, the precise relationship between 
TDs, especially subclinical forms, and IR is still under 
discussion. IR represents a key pathogenetic mechanism 
of cardiometabolic diseases, and its prevention is crucial 
in the current dominance of cardiometabolic diseases 
in overall mortality [6, 7]. 
In addition to serum thyroid hormones, some stud-
ies have discussed the relationship between T3/T4 ratio 
and various, mostly metabolic, parameters or clinical 
outcomes [8, 9]. The T3/T4 ratio is a calculated index used 
to indicate thyroid function and the action of hormones 
on the tissue. A method for detecting IR that is easy to 
use in common clinical practice is the homeostasis model 
assessment of IR (HOMA-IR). Its satisfactory correla-
tion with the most accurate glucose clamp techniques 
has been confirmed by numerous studies. Even fasting 
insulin levels alone reflect IR to some extent [10].
The study aimed to investigate the association of 
IR with defined TDs and thyroid function parameters, 
and through these findings, identify such thyroid dis-




The study comprised 1425 middle-aged individuals (317 males, 1108 
females) examined in a co-author’s internal medicine outpatient 
centre in Hradec Králové, Czech Republic. Data were collected in 
2009–2016 from the patients’ first visits to the centre. The labora-
tory analyses below, including standard 75 g oral glucose tolerance 
test (OGTT), were performed, and, at the same time, their basic 
anthropometric parameters (waist circumference [WC], weight, and 
height) were measured. The obtained data were used to calculate 
body mass index (BMI) and HOMA-IR for each participant. Based 
on their TSH and FT4 levels and the manufacturer’s instructions, 
all subjects were divided into subgroups according to Table 1. None 
of the included subjects was treated with oral antidiabetic drugs or 
Table 1. Study subgroups according to thyroid hormone levels
Subgroups/thyroid status TSH [mIU/L] FT4 [pmol/L]
Euthyroidism 0.4–4.0 and 9–23
Subclinical hypothyroidism > 4.0 and 9–23
Overt hypothyroidism > 4.0 and < 9
Hyperthyroidism < 0.4 or > 23
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two-hour glucose levels, which showed steady growth 
from euthyroidism through SH to OH.
Correlation analysis
The highest correlation coefficients of thyroid param-
eters were noted with insulin levels and HOMA-IR as 
seen from Table 3, namely correlations of insulin with 
the FT3/FT4 ratio (r = 0.206) and FT3 (r = 0.205), re-
spectively. Although the correlations were weak, they 
reached high statistical significance (p < 0.001). There 
were also highly significant correlations of both FT3 
and the FT3/FT4 ratio with HOMA-IR (r = 0.181 and 
r = 0.165, respectively). Figure 1 depicting the correla-
tions of the FT3/FT4 ratio suggests no difference be-
Table 2. Basic characteristics in study subgroups — mean value (95% confidence interval of the mean value)







































































































< 0.001 0.62 (0.61; 0.63)
BMI — body mass index; OGTT — oral glucose tolerance test; HOMA-IR — homeostasis model assessment of insulin resistance; TSH — thyroid-stimulating hormone; 
FT4 — free thyroxine; FT3 — free triiodothyronine
Table 3. Pearson’s correlation coefficients (r) of thyroid function parameters 
Characteristics TSH FT4 FT3 FT3/FT4
BMI 0.008 0.035 –0.055 –0.068*
Waist circumference 0.002 0.033 0.001 0.038
Glucose 0.014 0.064* 0.018 –0.029
Insulin –0.015 –0.081* 0.205** 0.206**
2-hour OGTT 0.007 –0.026 –0.007 0.044
HOMA-IR –0.015 –0.050 0.181** 0.165**
*p < 0.05, **p < 0.001; TSH — thyroid-stimulating hormone; FT4 — free thyroxine; FT3 — free triiodothyronine; BMI — body mass index; OGTT — oral glucose 
tolerance test; HOMA-IR — homeostasis model assessment of insulin resistance
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tween males and females. As for the parameters not as-
sociated with thyroid functions, there were statistically 
highly significant correlations of WC and body weight 
with both insulin and HOMA-IR, the strongest being 
correlated body weight with HOMA-IR (r = 0.494).
Regression analysis
The impact of individual IR predictors is expressed with 
multivariate linear regression models that use linear 
coefficients to show the effects of one-point increases 
of these predictors (independent variables) on the de-
pendent variables, HOMA-IR and insulin, respectively 
(Tab. 4). Except for the sex and age, the FT3/FT4 ratio 
was the only statistically significant predictor of both 
HOMA-IR and insulin. If the ratio increases by one 
point, HOMA-IR and insulin will increase by a mean of 
5.26 (p = 0.027) and 18.01 (p = 0.023), respectively. With 
each year of age, HOMA-IR and insulin will increase by 
a mean of 0.02 (p < 0.001) and 0.04 (p = 0.25), respec-
tively. Female sex was a significant predictor of a lower 
insulin level and HOMA-IR in our study population.
Discussion
The obtained results of the correlation analysis revealed 
only a few statistically significant and very weak asso-
ciations. The regression analysis confirmed a significant 
relationship only between IR and the FT3/FT4 ratio. The 
Table 4. Effects of every 1-point increase of independent variables on the dependent variables HOMA-IR and insulin
Independent 
variables
Linear coefficient Standard error t-value p-value
HOMA-IR Insulin HOMA-IR Insulin HOMA-IR Insulin HOMA-IR Insulin
Intercept –2.45 –5.82 1.33 4.44 –1.85 –1.31 0.065 0.19
Age 0.02 0.04 < 0.01 0.02 3.97 2.25 < 0.001 0.025
Sex (female) –0.8 –2.31 0.14 0.47 –5.75 –4.96 < 0.001 < 0.001
TSH –0.01 –0.05 0.02 0.05 –0.75 –0.96 0.455 0.338
FT4 0.16 0.44 0.12 0.39 1.39 1.12 0.166 0.261
FT3 0.04 0.23 0.25 0.84 0.17 0.27 0.862 0.785
FT3/FT4 ratio 5.26 18.01 2.37 7.92 2.22 2.27 0.027 0.023
HOMA-IR — homeostasis model assessment of insulin resistance; TSH — thyroid-stimulating hormone; FT4 — free thyroxine; FT3 — free triiodothyronine
Figure 1. Scatter diagrams showing correlations of free triiodothyronine/free thyroxine (FT3/FT4) ratio with fasting insulin levels (A) 
and HOMA-IR (B) with 95% confidence bands for the medians of variables on the y-axis for a given variable on the x-axis. There are 
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results also demonstrate both HOMA-IR and insulin 
levels increasing in the way from euthyroidism through 
SH to OH, although without statistical significance. 
Epidemiological evidence indicates that both OH and 
SH are connected with IR. Some studies showed a sta-
tistically significant increase of HOMA-IR and insulin 
levels in subjects with SH compared to the euthyroid 
[11, 12]. However, some findings showed no or insignifi-
cant difference between SH and the euthyroid state [13, 
14].  A study by Wang et al. also recorded an increase in 
HOMA-IR between SH and OH, as was the case in our 
study, although in our case without reaching statistical 
significance [12]. Comparable IR between SH and OH 
subjects was noted in a study by Maratou et al. [15]. We 
also demonstrate an increase of two-hour OGTT values 
in SH and OH compared to euthyroidism.
According to the population prevalence of TDs 
indicated in the introduction, hypothyroidism pre-
dominates. SH was estimated to affect up to 10%, with 
the highest prevalence among women and elderly 
individuals. However, SH frequently reverts to euthy-
roidism, and TSH levels rise as people without TDs 
age, making it likely that the prevalence of SH may be 
overestimated [2]. The occurrence of TDs in our study 
sample does not exactly correspond to the proposed 
population prevalence. However, the study did not 
comprise a random adult population, but rather pa-
tients of a stated outpatient centre.
The most common cause of hypothyroidism in 
iodine-sufficient populations is Hashimoto’s thyroiditis 
(HT). A chronic inflammation resulting from an imbal-
ance between pro-inflammatory and anti-inflammatory 
cytokines in HT might be responsible for IR in hypothy-
roidism. Subjects with highly positive thyroid peroxi-
dase antibodies (TPOabs) had elevated fasting insulin 
levels compared to those with lower titers of TPOabs, in 
a study by Mazarehi et al. [16]. OH was associated with 
obesity, promoting the production of pro-inflammatory 
cytokines and contributing to the development of IR. 
Moreover, BMI was positively correlated with TPOabs 
in men, suggesting that the pathogenesis of IR in hy-
pothyroidism is a complex and interrelated process [17, 
18]. In the present study, subjects with both SH and OH 
showed higher BMI values compared to euthyroidism.
Elevated levels of the FT3/FT4 ratio were associated 
with metabolic syndrome and some of its components 
such as obesity, elevated triglycerides, fasting blood 
glucose levels, and lower high-density lipoprotein 
cholesterol levels in euthyroid subjects [19, 20]. Based 
on regression analysis in a sample of 132,346 adults, 
Park et al. confirmed the FT3/FT4 ratio to have a better 
predictive power for metabolic syndrome than TSH 
[21]. In hypothyroidism and euthyroidism, as TSH 
levels rise the FT3/FT4 ratio also rises. Levothyroxine 
therapy was proved to decrease the FT3/FT4 ratio [22, 
23]. Given the association of both hypothyroidism and 
the FT3/FT4 ratio with IR, thyroxine supplementation 
in indicated cases may help not only in achieving eu-
thyroidism but also in improving IR. 
The study has certain limitations. We considered all 
hypothyroid subjects as having a peripheral form (not 
distinguishing between central and peripheral forms) 
of hypothyroidism. However, due to the low prevalence 
of central hypothyroidism, there should be no major 
bias for this reason.
Conclusion
Both SH and OH are associated with increased 
HOMA-IR, fasting insulin levels, and two-hour OGTT 
glucose levels compared to euthyroidism. From the 
common laboratory parameters of the thyroid gland, 
the FT3/FT4 ratio shows the strongest relationship to IR. 
The FT3/FT4 ratio should be more emphasised in the di-
agnosis and treatment of TDs. After further verification, 
pharmacological lowering of the ratio could be a pos-
sible targeted way to reverse the development of IR. 




The study was supported by the grant IGA_LF_UPOL 
2020_031.
References
1. Chaker L, Bianco A, Jonklaas J, et al. Hypothyroidism. Lancet. 2017; 
390(10101): 1550–1562, doi:  10.1016/s0140-6736(17)30703-1, indexed in 
Pubmed: 28336049.
2. Biondi B, Cappola AR, Cooper DS. Subclinical Hypothyroidism: A Re-
view. JAMA. 2019; 322(2): 153–160, doi: 10.1001/jama.2019.9052, indexed 
in Pubmed: 31287527.
3. Leo SDe, Lee S, Braverman L. Hyperthyroidism. Lancet. 2016; 
388(10047): 906–918, doi:  10.1016/s0140-6736(16)00278-6, indexed in 
Pubmed: 27038492.
4. Jabbar A, Pingitore A, Pearce SHS, et al. Thyroid hormones and cardio-
vascular disease. Nat Rev Cardiol. 2017; 14(1): 39–55, doi: 10.1038/nrcar-
dio.2016.174, indexed in Pubmed: 27811932.
5. Gierach M, Gierach J, Junik R. Insulin resistance and thyroid disor-
ders. Endokrynol Pol. 2014; 65: 70–76, doi: 10.5603/EP.2014.0010, indexed 
in Pubmed: 24549605.
6. Garduño-Garcia Jd, Camarillo Romero E, Loe Ochoa A, et al. Thyroid 
function is associated with insulin resistance markers in healthy adoles-
cents with risk factors to develop diabetes. Diabetol Metab Syndr. 2015; 
7: 16, doi: 10.1186/s13098-015-0011-x, indexed in Pubmed: 25780389.
7. Samuel VT, Shulman GI. The pathogenesis of insulin resistance: integrat-
ing signaling pathways and substrate flux. J Clin Invest. 2016; 126(1): 
12–22, doi: 10.1172/JCI77812, indexed in Pubmed: 26727229.
8. Emokpae MA, Obazelu PA. The Association of Triiodothyronine-to-Thy-
roxine Ratio with Body Mass Index in Obese Nigerian Children and 
Adolescents. Med Sci (Basel). 2017; 5(4), doi: 10.3390/medsci5040036, 
indexed in Pubmed: 29244733.
9. Pasqualetti G, Schirripa M, Dochy E, et al. Thyroid hormones ratio is 
a major prognostic marker in advanced metastatic colorectal cancer: 
Results from the phase III randomised CORRECT trial. Eur J Cancer. 
2020; 133: 66–73, doi:  10.1016/j.ejca.2020.04.023, indexed in Pubmed:
32446145.
13










10. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA model-
ing. Diabetes Care. 2004; 27(6): 1487–1495, doi: 10.2337/diacare.27.6.1487, 
indexed in Pubmed: 15161807.
11. Ebrahimpour A, Vaghari-Tabari M, Qujeq D, et al. Direct correlation 
between serum homocysteine level and insulin resistance index in 
patients with subclinical hypothyroidism: Does subclinical hypothyroid-
ism increase the risk of diabetes and cardio vascular disease together? 
Diabetes Metab Syndr. 2018; 12(6): 863–867, doi: 10.1016/j.dsx.2018.05.002, 
indexed in Pubmed: 29748035.
12. Wang G, Liu J, Yang N, et al. Levothyroxine treatment restored the 
decreased circulating fibroblast growth factor 21 levels in patients 
with hypothyroidism. Eur J Intern Med. 2016; 31: 94–98, doi: 10.1016/j.
ejim.2016.03.028, indexed in Pubmed: 27085392.
13. Maleki N, Kazerouni F, Hedayati M, et al. Assessment of cardiovas-
cular risk factors in patients with subclinical hypothyroidism. Acta 
Cardiol. 2016; 71(6): 691–697, doi: 10.2143/AC.71.6.3178188, indexed in 
Pubmed: 27920457.
14. Aksoy N, Yeler MT, Ayan NN, et al. Association between thyroid hor-
mone levels and insulin resistance and body mass index. Pak J Med 
Sci. 2015; 31(6): 1417–1420, doi:  10.12669/pjms.316.7560, indexed in 
Pubmed: 26870107.
15. Maratou E, Hadjidakis DJ, Kollias A, et al. Studies of insulin resistance 
in patients with clinical and subclinical hypothyroidism. Eur J En-
docrinol. 2009; 160(5): 785–790, doi:  10.1530/EJE-08-0797, indexed in 
Pubmed: 19141606.
16. Mazaheri T, Sharifi F, Kamali K. Insulin resistance in hypothyroid patients 
under Levothyroxine therapy: a comparison between those with and 
without thyroid autoimmunity. J Diabetes Metab Disord. 2014; 13(1): 103, 
doi: 10.1186/s40200-014-0103-4, indexed in Pubmed: 25364704.
17. Sanyal D, Raychaudhuri M. Hypothyroidism and obesity: An 
intriguing link. Indian J Endocrinol Metab. 2016; 20(4): 554–557, 
doi: 10.4103/2230-8210.183454, indexed in Pubmed: 27366725.
18. Wang B, Song R, He W, et al. Sex Differences in the Associations of 
Obesity With Hypothyroidism and Thyroid Autoimmunity Among Chi-
nese Adults. Front Physiol. 2018; 9: 1397, doi: 10.3389/fphys.2018.01397, 
indexed in Pubmed: 30337885.
19. Xu R, Huang F, Zhang S, et al. Thyroid function, body mass index, 
and metabolic risk markers in euthyroid adults: a cohort study. BMC 
Endocr Disord. 2019; 19(1): 58, doi: 10.1186/s12902-019-0383-2, indexed 
in Pubmed: 31174521.
20. Urrunaga-Pastor D, Guarnizo-Poma M, Moncada-Mapelli E, et al. Insulin 
Resistance and Metabolic Syndrome Research Group. High free triiodo-
thyronine and free-triiodothyronine-to-free-thyroxine ratio levels are 
associated with metabolic syndrome in a euthyroid population. Diabetes 
Metab Syndr. 2018; 12(2): 155–161, doi: 10.1016/j.dsx.2017.12.003, indexed 
in Pubmed: 29254889.
21. Park SoY, Park SeE, Jung SW, et al. Free triiodothyronine/free thyroxine 
ratio rather than thyrotropin is more associated with metabolic param-
eters in healthy euthyroid adult subjects. Clin Endocrinol (Oxf). 2017; 
87(1): 87–96, doi: 10.1111/cen.13345, indexed in Pubmed: 28374508.
22. Ettleson MD, Bianco AC. Individualized Therapy for Hypothyroidism: 
Is T4 Enough for Everyone? J Clin Endocrinol Metab. 2020; 105(9), 
doi: 10.1210/clinem/dgaa430, indexed in Pubmed: 32614450.
23. Strich D, Chay C, Karavani G, et al. Levothyroxine Therapy Achieves 
Physiological FT3/FT4 Ratios at Higher than Normal TSH Lev-
els: A Novel Justification for T3 Supplementation? Horm Metab 
Res. 2018; 50(11): 827–831, doi: 10.1055/a-0751-0498, indexed in Pubmed:
30396211.
